Is there a prostate-specific antigen upper limit for radical prostatectomy?

Gontero, Paulo;Spahn, Martin;Tombal, Bertrand;Bader, Pia;Joniau, Steven;et.al.
(2011) BJU International — Vol. 108, n° 7, p. 1093-1100 (2011)

Files

Gontero-2011-Isthereaprostate-.pdf
  • Restricted Access
  • Adobe PDF
  • 489.45 KB
Request a copy

Details

Authors
  • Gontero, Paulo
    Author
  • Spahn, Martin
    Author
  • Tombal, Bertrandorcid-logoUCLouvain
    Author
  • Bader, Pia
    Author
  • Joniau, Steven
    Author
Show more
Abstract
• To assess the feasibility of radical prostatectomy (RP) in a series of patients with prostate cancer with very high prostate-specific antigen (PSA) levels by comparing the clinical outcomes of different PSA thresholds (20.1-50 ng/mL, 50.1-100 ng/mL and >100 ng/mL, respectively).
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Gontero, P., Spahn, M., Tombal, B., Bader, P., Hsu, C.-Y., Marchioro, G., Frea, B., Van Der Eeckt, K., Kneitz, B., Frohneberg, D., Tizzani, A., Van Poppel, H., & Joniau, S. (2011). Is there a prostate-specific antigen upper limit for radical prostatectomy? BJU International, 108(7), 1093-1100. https://doi.org/10.1111/j.1464-410X.2011.10076.x (Original work published 2011)